Proteomics and metabolomics analyses reveal the full spectrum of inflammatory and lipid metabolic abnormalities in dyslipidemia
- 31 May 2021
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 35 (10) , e5183
Abstract
Dyslipidemia is a common, chronic metabolic disease associated with cardiovascular complications. Due to the multiplicity of etiological factors, the pathogenesis of dyslipidemia is still unclear. In this study, we combined proteomics and metabolomics methods to analyze the plasma of patients with dyslipidemia and healthy subjects. isobaric tags for relative and absolute quantification (iTRAQ) markers, combined with LC–MS/MS proteomics technology and the UHPLC/Orbitfast‐X Tribrid system, were used to establish the metabolite profile in clinical dyslipidemia. A total of 137 differentially expressed proteins, mainly related to biological processes such as protein activation cascades, adaptive immune responses, complement activation, acute inflammatory responses, and regulation of acute inflammatory responses, were identified. These proteins are involved in the regulation of important metabolic pathways, such as immunity and inflammation, coagulation and hemostasis, lipid metabolism, and oxidation and antioxidant defenses. The analysis of clinical metabolites showed there were 69 different metabolites in plasma, mainly related to glycerolipid, sphingolipid, porphyrin, α‐linolenic acid, linoleic acid, and arachidonic acid metabolism, suggesting that the regulation of inflammation and lipid metabolism may be disturbed in patients with dyslipidemia. Among these, significant changes were observed in indole‐3‐propionic acid (IPA), which is considered as a potential biomarker of dyslipidemia. The combined analysis of proteins and metabolites showed that arachidonic acid, linoleic acid, and lipid metabolic pathways were closely related to dyslipidemia. IPA may be a potential biomarker. The information provided in this study may provide new insights into the pathogenesis of animal models of dyslipidemia and related disease models, as well as potential intervention targets.Keywords
All Related Versions
Funding Information
- Jiangxi University of Traditional Chinese Medicine
This publication has 34 references indexed in Scilit:
- Secretome-Derived Isotope Tags (SDIT) Reveal Adipocyte-Derived Apolipoprotein C-I as a Predictive Marker for Cardiovascular DiseaseJournal of Proteome Research, 2012
- The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune NeuritisJournal of Biomedicine and Biotechnology, 2010
- Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolitesProceedings of the National Academy of Sciences, 2009
- Increased Arachidonic Acid‐Induced Thromboxane Generation Impairs Skeletal Muscle Arteriolar Dilation with Genetic DyslipidemiaMicrocirculation, 2008
- Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjectsJournal of Lipid Research, 2007
- Prevalence of Dyslipidemia in Non-Obese Prepubertal Children and its Association with Family History of Diabetes, High Blood Pressure, and ObesityArchives of Medical Research, 2006
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006
- Absorption and lipoprotein transport of sphingomyelinJournal of Lipid Research, 2006
- Mass spectrometry-based proteomicsNature, 2003
- Lipid peroxides and atherosclerosis.BMJ, 1989